Evidence map›Paper›PMID 27374096›Full record

ArticleOncotarget2016

Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).

Coralie Moncharmont, Jean-Baptiste Guy, Anne-Sophie Wozny, Marion Gilormini, Priscilla Battiston-Montagne, Dominique Ardail, Michael Beuve, Gersende Alphonse, Xavier Simoëns, Chloé Rancoule and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Basic and translational research on carbon-ion radiobiology.American journal of cancer research · 2023
    Review
  5. Frontiers in oncology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Anti-EGFR treatment effects on laryngeal cancer stem cells.American journal of translational research · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Coralie MoncharmontUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Jean-Baptiste GuyUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Anne-Sophie WoznyUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Marion GilorminiUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Priscilla Battiston-MontagneUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Dominique ArdailUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Michael BeuveInstitut de Physique Nucléaire de Lyon, IPNL, Villeurbanne, 69622, France.
Gersende AlphonseLaboratoire de Radiobiologie Cellulaire et Moléculaire, Institut de Physique Nucléaire de Lyon, IPNL, Villeurbanne, 69622, France.
Xavier SimoënsDépartement de Pharmacologie Clinique et d'Innovation, Institut de Cancérologie de la Loire - Lucien Neuwirth, St Priest en Jarez, 42270, France.
Chloé RancouleDépartement de Radiothérapie, Institut de Cancérologie de la Loire - Lucien Neuwirth, St Priest en Jarez, 42270, France.
Claire Rodriguez-LafrasseUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Nicolas MagnéUniversité Lyon 1, Faculté de Médecine-Lyon-Sud, Oullins, 69921, France.
Université Claude Bernard Lyon 1 · FRInstitute Cancer De La Loire Lucien Neuwirth · FRHôpital Lyon Sud · FRInstitute of Nuclear Physics of Lyon · FRHCL Technologies (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer Stem Cells (CSCs) in Head and Neck Squamous Cell Carcinoma (HNSCC) have extremely aggressive profile (high migratory and invasive potential). These characteristics can explain their resistance to conventional treatment. Efficacy of photon and carbon ion irradiation with addition of cetuximab (5 nM) is studied on clonogenic death, migration and invasion of two HNSCC populations: SQ20B and SQ20B/CSCs. SQ20B express E-cadherin and overexpress EGFR while SQ20B/CSCs express N-cadherin and low EGFR. Cetuximab strongly inhibits SQ20B proliferation but has no effect on SQ20B/CSCs. 2 Gy photon irradiation enhances migration and invasiveness in both populations (p < 0.05), while cetuximab only stops SQ20B migration (p < 0.005). Carbon irradiation significantly inhibits invasion in both populations (p < 0.05), and the association with cetuximab significantly inhibits invasion in both populations (p < 0.005). These results highlight CSCs characteristics: EGFRLow, cetuximab-resistant, and highly migratory. Carbon ion irradiation appears to be a very promising therapeutic modality counteracting migration/invasion process in both parental cells and CSCs in contrast to photon irradiation.

Indexed as

Carcinoma, Squamous CellCell Line, TumorCell MovementCell ProliferationCetuximabChemoradiotherapyEpithelial-Mesenchymal TransitionErbB ReceptorsHead and Neck NeoplasmsHeavy Ion RadiotherapyHumansNeoplasm InvasivenessNeoplastic Stem CellsPhotonsSquamous Cell Carcinoma of Head and NeckSurvival AnalysisCetuximabEGFR protein, humanErbB Receptorscancer stem cellscarbon ion irradiationHNSCCinvasionmigration

Identifiers

PMID27374096
PMCPMC5216975
OpenAlexW2463838160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.